Mechanistic evaluation of the role of circadian rhythms in acute lung injury and subsequent recovery

昼夜节律在急性肺损伤及随后恢复中作用的机制评估

基本信息

  • 批准号:
    10686064
  • 负责人:
  • 金额:
    $ 62.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-20 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary Our overall aim is to define the mechanisms underlying the circadian regulation of acute lung injury and subsequent recovery. Our published work shows that circadian rhythms confer a time of day specific protection from Influenza A Virus (IAV) infection. Mice infected at dawn had 3-fold better survival than those infected at dusk. While, we cannot clinically control the time of exposure to IAV, these data suggest that altering the circadian health of the host could affect outcomes. In fact, disrupting circadian rhythms genetically in mice, by deleting the core clock gene, Bmal1, worsened mortality from IAV. Further proof of the translational relevance of our mechanistic work came from our analyses of the UK biobank which revealed that disrupted circadian rhythms was an independent risk factor for Influenza related hospitalization. Severe influenza infection is characterized by extensive immunopathology and dysplastic lung repair and regeneration, often independent of viral burden. Both vaccines and anti-viral agents have limited efficacy. The current proposal addresses this need in the field by exploring a novel target—circadian rhythms as determinant of outcomes in IAV. Since the last submission, we have generated exciting preliminary data that shows that disruption of the AT2 clock is associated with (a) worse acute mortality, immunopathology and necroptosis and (b) delayed recovery in vivo and poor regeneration on organoid assays. Our overall goals are to: (1) Test the hypothesis that the disruption of the AT2 clock leads to a pro-inflammatory state at baseline that is further exacerbated by IAV infection, thereby worsening necroptosis. (2) To test the hypothesis that the circadian clock contributes to lung regeneration through Wnt- responsive regulation of the cell cycle via the Axin2+ epithelial niche. Our approach employs tissue specific circadian knock-out models induced in adulthood, circadian sampling throughout 24hrs, other genetic/environmental models of circadian disruption and tools form lung regenerative biology, customized to the circadian context. I have also gathered an outstanding team of collaborators and consultants with expertise in cell death, circadian bioinformatics, lung regeneration and virology. Elucidating these mechanisms is the critical next step towards modulating the host circadian rhythms for therapeutic purposes. While, we use influenza as our model, the principles uncovered thus, should be generalizable to other viral conditions of the lung.
项目摘要 我们的总体目标是明确急性肺损伤的昼夜节律机制。 以及随后的恢复。我们发表的研究表明,昼夜节律赋予一天中特定的时间 预防甲型流感病毒(IAV)感染。黎明时分感染的小鼠的存活率是那些 在黄昏时被感染。虽然临床上我们不能控制暴露于IAV的时间,但这些数据表明 改变宿主的昼夜健康状况可能会影响结果。事实上,从基因上扰乱昼夜节律 在小鼠中,通过删除核心时钟基因BMal1,可以恶化IAV的死亡率。翻译的进一步证明 我们机械工作的相关性来自于我们对英国生物库的分析,该分析揭示了 昼夜节律是流感相关住院的独立危险因素。严重流感 感染的特点是广泛的免疫病理和发育不良的肺修复和再生,通常 与病毒负担无关。疫苗和抗病毒药物的效果都有限。目前的提案 通过探索一个新的目标-昼夜节律作为结果的决定因素,满足了现场的这一需求 IAV.自上次提交以来,我们产生了令人兴奋的初步数据,表明 AT2时钟与(A)更严重的急性死亡率、免疫病理学和坏死性下垂有关,以及(B) 体内恢复延迟,有机物检测再生能力差。我们的总体目标是: (1)测试AT2时钟中断会导致促炎状态的假设 这一基线因IAV感染而进一步加重,从而加重了坏死性下垂。 (2)检验生物钟通过Wnt-2促进肺再生的假说。 通过Axin2+上皮龛对细胞周期的响应调节。 我们的方法使用成年期诱导的组织特异性昼夜节律敲除模型,昼夜节律采样 在整个24小时内,其他遗传/环境的昼夜节律紊乱模型和工具形成肺再生。 生物学,为昼夜节律环境定制的。我还召集了一支优秀的合作者团队, 拥有细胞死亡、昼夜生物信息学、肺再生和病毒学专业知识的顾问。澄清 这些机制是调节宿主昼夜节律以进行治疗的关键下一步。 目的。虽然我们使用流感作为我们的模型,但由此揭示的原理应该可以推广到 肺部的其他病毒性疾病。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shaon Sengupta其他文献

Shaon Sengupta的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shaon Sengupta', 18)}}的其他基金

Mechanistic evaluation of the role of circadian rhythms in acute lung injury and subsequent recovery
昼夜节律在急性肺损伤及随后恢复中作用的机制评估
  • 批准号:
    10491281
  • 财政年份:
    2021
  • 资助金额:
    $ 62.08万
  • 项目类别:
Mechanistic evaluation of the role of circadian rhythms in acute lung injury and subsequent recovery
昼夜节律在急性肺损伤及随后恢复中作用的机制评估
  • 批准号:
    10299011
  • 财政年份:
    2021
  • 资助金额:
    $ 62.08万
  • 项目类别:
Role of Circadian Clock in Lung Inflammation
昼夜节律钟在肺部炎症中的作用
  • 批准号:
    9314903
  • 财政年份:
    2017
  • 资助金额:
    $ 62.08万
  • 项目类别:
Role of Circadian Clock in Lung Inflammation
昼夜节律钟在肺部炎症中的作用
  • 批准号:
    10005413
  • 财政年份:
    2017
  • 资助金额:
    $ 62.08万
  • 项目类别:

相似海外基金

Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
  • 批准号:
    10648387
  • 财政年份:
    2023
  • 资助金额:
    $ 62.08万
  • 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
  • 批准号:
    10720687
  • 财政年份:
    2023
  • 资助金额:
    $ 62.08万
  • 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
  • 批准号:
    10719249
  • 财政年份:
    2023
  • 资助金额:
    $ 62.08万
  • 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
  • 批准号:
    10591804
  • 财政年份:
    2023
  • 资助金额:
    $ 62.08万
  • 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
  • 批准号:
    10741574
  • 财政年份:
    2023
  • 资助金额:
    $ 62.08万
  • 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
  • 批准号:
    23K07651
  • 财政年份:
    2023
  • 资助金额:
    $ 62.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
  • 批准号:
    10679944
  • 财政年份:
    2023
  • 资助金额:
    $ 62.08万
  • 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
  • 批准号:
    10575258
  • 财政年份:
    2023
  • 资助金额:
    $ 62.08万
  • 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
  • 批准号:
    10701207
  • 财政年份:
    2023
  • 资助金额:
    $ 62.08万
  • 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
  • 批准号:
    MR/Y000404/1
  • 财政年份:
    2023
  • 资助金额:
    $ 62.08万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了